Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
NCT ID: NCT07335627
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
260 participants
OBSERVATIONAL
2025-02-21
2026-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis of this study is that clindamycin is no less effective than other drugs commonly used to treat periprosthetic Streptococcus spp. infections.
The primary objective of this study is to evaluate the success rate of Streptococcus spp. periprosthetic joint infections treated with clindamycin compared to other antibiotic treatments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Or v IV Antibiotics for Infection
NCT04723940
Clindamycin-rifampin Drug Interaction in the Treatment of Bone and Joint Infections
NCT02629770
Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)
NCT01500837
Clinical Evaluation of Daptomycin Bone Penetration
NCT01306825
Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections
NCT02782078
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Probable or proven periprosthetic infection with Streptococcus spp. according to EBJIS diagnostic criteria
* Patient operated on in one of the associated centers between 2013 and 2024
Exclusion Criteria
* Patient who was treated with suppressive antibiotic therapy (defined as antibiotic treatment lasting more than 6 months) which was decided upon prior to surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Chirurgie Orthopédique Septique - CHU de Strasbourg - France
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9536
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.